Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients

Authors :: M. Del Re
C. Omarini
L. Diodati
M. Palleschi
I. Meattini
S. Crucitta
G. Lorenzini
C. Isca
A. Fontana
L. Livi
F. Piacentini
S. Fogli
U. De Giorgi
R. Danesi
Publication Year :: 2022

Subjects :: Cancer Research
Oncology
Drug Interactions
Female
Humans
Piperazines
Pyridines
Breast Neoplasms
Proton Pump Inhibitors

Tools